BIOSPRING Trademark

Trademark Overview


On Tuesday, March 14, 2023, a trademark application was filed for BIOSPRING with the United States Patent and Trademark Office. The USPTO has given the BIOSPRING trademark a serial number of 97839291. The federal status of this trademark filing is REGISTERED as of Tuesday, April 2, 2024. This trademark is owned by BioSpring Gesellschaft für Biotechnologie GmbH. The BIOSPRING trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

biochemical contract manufacturing services; chemical synthesis services, namely, custom synthesis of chemicals for others; custom manufacture of biopharmaceuticals; custom manufacture of pharmaceuticals; custom manufacturing of oligonucleotides; custom modification of antibody; custom modification of protein; development services, namely, design and development of manufacturing processes for others in the field of oligonucleotides; manufacturing, namely, contract manufacturing in the field of oligonucleotides; processing of biopharmaceutical materials for others; processing of chemical reagents; processing of chemicals; processing of medicinal materials; processing of oligonucleotides; processing of peptides; processing of proteins; technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing

nucleic acid reagents, agents, preparations and substances for medical purposes; nucleic acid sequences for medical and veterinary use; oligonucleotides for diagnostic purposes; oligonucleotides for medical diagnostic purposes; oligonucleotides for medical use; oligonucleotides for pharmaceutical purposes; pharmaceutical preparations against genetic diseases; pharmaceutical preparations against metabolic diseases; pharmaceutical preparations against neurological diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; pharmaceutical preparations for wound healing; reagents for medical purposes; reag...

oligonucleotides for use in the manufacture of pharmaceuticals; oligopeptides for industrial use; peptide substrates for scientific use; peptides for use in industry and science; peptides for use in research and the manufacture of reagents, diagnostic reagents for science and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; phosphoproteins; proteins for use in industry and science; reagents for research purposes; reagents for scientific use; nucleic acid for diagnostic research; nucleic acid for diagnostic manufacturing

nucleic acid analysis for medical diagnostic and treatment purposes; oligonucleotide analysis for medical diagnostic and treatment purposes

scientific analysis services for the identification and physical characterization of chemical molecules; scientific and technical services, namely, scientific analysis of industrial installations; scientific and technological services, namely, applied scientific research and development services, namely, conception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; scientific and technological services, namely, consulting and assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and installations; scientific and technological services, namely, consulting and assistance in the research and development of pharmaceuticals; scientific development services in the field of biochemistry; scientific laboratory services; scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic...
biospring

General Information


Serial Number97839291
Word MarkBIOSPRING
Filing DateTuesday, March 14, 2023
Status700 - REGISTERED
Status DateTuesday, April 2, 2024
Registration Number7345913
Registration DateTuesday, April 2, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements


Goods and Servicesbiochemical contract manufacturing services; chemical synthesis services, namely, custom synthesis of chemicals for others; custom manufacture of biopharmaceuticals; custom manufacture of pharmaceuticals; custom manufacturing of oligonucleotides; custom modification of antibody; custom modification of protein; development services, namely, design and development of manufacturing processes for others in the field of oligonucleotides; manufacturing, namely, contract manufacturing in the field of oligonucleotides; processing of biopharmaceutical materials for others; processing of chemical reagents; processing of chemicals; processing of medicinal materials; processing of oligonucleotides; processing of peptides; processing of proteins; technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing
Goods and Servicesnucleic acid reagents, agents, preparations and substances for medical purposes; nucleic acid sequences for medical and veterinary use; oligonucleotides for diagnostic purposes; oligonucleotides for medical diagnostic purposes; oligonucleotides for medical use; oligonucleotides for pharmaceutical purposes; pharmaceutical preparations against genetic diseases; pharmaceutical preparations against metabolic diseases; pharmaceutical preparations against neurological diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; pharmaceutical preparations for wound healing; reagents for medical purposes; reagents for medical use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; tumor suppressing agents
Pseudo MarkBIO SPRING
Goods and Servicesoligonucleotides for use in the manufacture of pharmaceuticals; oligopeptides for industrial use; peptide substrates for scientific use; peptides for use in industry and science; peptides for use in research and the manufacture of reagents, diagnostic reagents for science and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; phosphoproteins; proteins for use in industry and science; reagents for research purposes; reagents for scientific use; nucleic acid for diagnostic research; nucleic acid for diagnostic manufacturing
Goods and Servicesnucleic acid analysis for medical diagnostic and treatment purposes; oligonucleotide analysis for medical diagnostic and treatment purposes
Goods and Servicesscientific analysis services for the identification and physical characterization of chemical molecules; scientific and technical services, namely, scientific analysis of industrial installations; scientific and technological services, namely, applied scientific research and development services, namely, conception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; scientific and technological services, namely, consulting and assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and installations; scientific and technological services, namely, consulting and assistance in the research and development of pharmaceuticals; scientific development services in the field of biochemistry; scientific laboratory services; scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of chemistry and biochemistry; scientific research and development services in the field of pharmaceuticals; scientific research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes; scientific research services, namely, nucleic acid analysis; scientific research services, namely, oligonucleotide analysis; scientific services, namely, scientific analysis allowing the identification and physical characterization of chemical molecules; scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bio-organics; scientific study and research services in the field of industrial safety

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, April 4, 2023
Primary Code001
First Use Anywhere DateSunday, April 30, 2017
First Use In Commerce DateSunday, April 30, 2017

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 4, 2023
Primary Code005
First Use Anywhere DateSunday, April 30, 2017
First Use In Commerce DateSunday, April 30, 2017

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, April 4, 2023
Primary Code040
First Use Anywhere DateSunday, April 30, 2017
First Use In Commerce DateSunday, April 30, 2017

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 4, 2023
Primary Code042
First Use Anywhere DateSunday, April 30, 2017
First Use In Commerce DateSunday, April 30, 2017

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 4, 2023
Primary Code044
First Use Anywhere DateSunday, April 30, 2017
First Use In Commerce DateSunday, April 30, 2017

Trademark Owner History


Party NameBioSpring Gesellschaft für Biotechnologie GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressFranfurt 60386
DE

Party NameBioSpring Gesellschaft für Biotechnologie GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFranfurt 60386
DE

Party NameBioSpring Gesellschaft für Biotechnologie GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFranfurt 60386
DE

Trademark Events


Event DateEvent Description
Friday, March 17, 2023NEW APPLICATION ENTERED
Tuesday, April 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 24, 2023TEAS AMENDMENT OF USE RECEIVED
Friday, August 25, 2023USE AMENDMENT FILED
Friday, August 25, 2023AMENDMENT TO USE PROCESSING COMPLETE
Monday, December 11, 2023ASSIGNED TO EXAMINER
Wednesday, December 13, 2023USE AMENDMENT ACCEPTED
Wednesday, December 13, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 13, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, December 13, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 13, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, December 14, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, December 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 10, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 17, 2024POST REGISTRATION ACTION MAILED - SEC. 7
Friday, April 12, 2024TEAS SECTION 7 REQUEST RECEIVED